A detailed history of Blue Investment Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Blue Investment Partners LLC holds 240 shares of LLY stock, worth $221,690. This represents 0.1% of its overall portfolio holdings.

Number of Shares
240
Holding current value
$221,690
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $173,968 - $218,169
240 New
240 $217,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $878B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Blue Investment Partners LLC Portfolio

Follow Blue Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Investment Partners LLC with notifications on news.